220 related articles for article (PubMed ID: 21507633)
1. The discovery of novel benzofuran-2-carboxylic acids as potent Pim-1 inhibitors.
Xiang Y; Hirth B; Asmussen G; Biemann HP; Bishop KA; Good A; Fitzgerald M; Gladysheva T; Jain A; Jancsics K; Liu J; Metz M; Papoulis A; Skerlj R; Stepp JD; Wei RR
Bioorg Med Chem Lett; 2011 May; 21(10):3050-6. PubMed ID: 21507633
[TBL] [Abstract][Full Text] [Related]
2. Identification and structure-activity relationships of substituted pyridones as inhibitors of Pim-1 kinase.
Cheney IW; Yan S; Appleby T; Walker H; Vo T; Yao N; Hamatake R; Hong Z; Wu JZ
Bioorg Med Chem Lett; 2007 Mar; 17(6):1679-83. PubMed ID: 17251021
[TBL] [Abstract][Full Text] [Related]
3. A crystallographic fragment screen identifies cinnamic acid derivatives as starting points for potent Pim-1 inhibitors.
Schulz MN; Fanghänel J; Schäfer M; Badock V; Briem H; Boemer U; Nguyen D; Husemann M; Hillig RC
Acta Crystallogr D Biol Crystallogr; 2011 Mar; 67(Pt 3):156-66. PubMed ID: 21358046
[TBL] [Abstract][Full Text] [Related]
4. Computational analysis of benzofuran-2-carboxlic acids as potent Pim-1 kinase inhibitors.
Wadood A; Jamal SB; Riaz M; Mir A
Pharm Biol; 2014 Sep; 52(9):1170-8. PubMed ID: 24766364
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and SAR of highly selective MMP-13 inhibitors.
Li J; Rush TS; Li W; DeVincentis D; Du X; Hu Y; Thomason JR; Xiang JS; Skotnicki JS; Tam S; Cunningham KM; Chockalingam PS; Morris EA; Levin JI
Bioorg Med Chem Lett; 2005 Nov; 15(22):4961-6. PubMed ID: 16153831
[TBL] [Abstract][Full Text] [Related]
6. New potent dual inhibitors of CK2 and Pim kinases: discovery and structural insights.
López-Ramos M; Prudent R; Moucadel V; Sautel CF; Barette C; Lafanechère L; Mouawad L; Grierson D; Schmidt F; Florent JC; Filippakopoulos P; Bullock AN; Knapp S; Reiser JB; Cochet C
FASEB J; 2010 Sep; 24(9):3171-85. PubMed ID: 20400536
[TBL] [Abstract][Full Text] [Related]
7. The discovery of fused pyrrole carboxylic acids as novel, potent D-amino acid oxidase (DAO) inhibitors.
Sparey T; Abeywickrema P; Almond S; Brandon N; Byrne N; Campbell A; Hutson PH; Jacobson M; Jones B; Munshi S; Pascarella D; Pike A; Prasad GS; Sachs N; Sakatis M; Sardana V; Venkatraman S; Young MB
Bioorg Med Chem Lett; 2008 Jun; 18(11):3386-91. PubMed ID: 18455394
[TBL] [Abstract][Full Text] [Related]
8. Isoxazolo[3,4-b]quinoline-3,4(1H,9H)-diones as unique, potent and selective inhibitors for Pim-1 and Pim-2 kinases: chemistry, biological activities, and molecular modeling.
Tong Y; Stewart KD; Thomas S; Przytulinska M; Johnson EF; Klinghofer V; Leverson J; McCall O; Soni NB; Luo Y; Lin NH; Sowin TJ; Giranda VL; Penning TD
Bioorg Med Chem Lett; 2008 Oct; 18(19):5206-8. PubMed ID: 18790640
[TBL] [Abstract][Full Text] [Related]
9. A novel Pim-1 kinase inhibitor targeting residues that bind the substrate peptide.
Tsuganezawa K; Watanabe H; Parker L; Yuki H; Taruya S; Nakagawa Y; Kamei D; Mori M; Ogawa N; Tomabechi Y; Handa N; Honma T; Yokoyama S; Kojima H; Okabe T; Nagano T; Tanaka A
J Mol Biol; 2012 Mar; 417(3):240-52. PubMed ID: 22306408
[TBL] [Abstract][Full Text] [Related]
10. Discovery of 3H-benzo[4,5]thieno[3,2-d]pyrimidin-4-ones as potent, highly selective, and orally bioavailable inhibitors of the human protooncogene proviral insertion site in moloney murine leukemia virus (PIM) kinases.
Tao ZF; Hasvold LA; Leverson JD; Han EK; Guan R; Johnson EF; Stoll VS; Stewart KD; Stamper G; Soni N; Bouska JJ; Luo Y; Sowin TJ; Lin NH; Giranda VS; Rosenberg SH; Penning TD
J Med Chem; 2009 Nov; 52(21):6621-36. PubMed ID: 19842661
[TBL] [Abstract][Full Text] [Related]
11. Discovery, SAR and X-ray structure of 1H-benzimidazole-5-carboxylic acid cyclohexyl-methyl-amides as inhibitors of inducible T-cell kinase (Itk).
Moriarty KJ; Takahashi H; Pullen SS; Khine HH; Sallati RH; Raymond EL; Woska JR; Jeanfavre DD; Roth GP; Winters MP; Qiao L; Ryan D; DesJarlais R; Robinson D; Wilson M; Bobko M; Cook BN; Lo HY; Nemoto PA; Kashem MA; Wolak JP; White A; Magolda RL; Tomczuk B
Bioorg Med Chem Lett; 2008 Oct; 18(20):5545-9. PubMed ID: 18819799
[TBL] [Abstract][Full Text] [Related]
12. Implications of promiscuous Pim-1 kinase fragment inhibitor hydrophobic interactions for fragment-based drug design.
Good AC; Liu J; Hirth B; Asmussen G; Xiang Y; Biemann HP; Bishop KA; Fremgen T; Fitzgerald M; Gladysheva T; Jain A; Jancsics K; Metz M; Papoulis A; Skerlj R; Stepp JD; Wei RR
J Med Chem; 2012 Mar; 55(6):2641-8. PubMed ID: 22339127
[TBL] [Abstract][Full Text] [Related]
13. Hit to lead evaluation of 1,2,3-triazolo[4,5-b]pyridines as PIM kinase inhibitors.
Pastor J; Oyarzabal J; Saluste G; Alvarez RM; Rivero V; Ramos F; Cendón E; Blanco-Aparicio C; Ajenjo N; Cebriá A; Albarrán MI; Cebrián D; Corrionero A; Fominaya J; Montoya G; Mazzorana M
Bioorg Med Chem Lett; 2012 Feb; 22(4):1591-7. PubMed ID: 22266039
[TBL] [Abstract][Full Text] [Related]
14. Discovery of a novel class of non-ATP site DFG-out state p38 inhibitors utilizing computationally assisted virtual fragment-based drug design (vFBDD).
Moffett K; Konteatis Z; Nguyen D; Shetty R; Ludington J; Fujimoto T; Lee KJ; Chai X; Namboodiri H; Karpusas M; Dorsey B; Guarnieri F; Bukhtiyarova M; Springman E; Michelotti E
Bioorg Med Chem Lett; 2011 Dec; 21(23):7155-65. PubMed ID: 22014550
[TBL] [Abstract][Full Text] [Related]
15. Rational evolution of a novel type of potent and selective proviral integration site in Moloney murine leukemia virus kinase 1 (PIM1) inhibitor from a screening-hit compound.
Nakano H; Saito N; Parker L; Tada Y; Abe M; Tsuganezawa K; Yokoyama S; Tanaka A; Kojima H; Okabe T; Nagano T
J Med Chem; 2012 Jun; 55(11):5151-64. PubMed ID: 22540945
[TBL] [Abstract][Full Text] [Related]
16. Structure-based design of 3-aryl-6-amino-triazolo[4,3-b]pyridazine inhibitors of Pim-1 kinase.
Grey R; Pierce AC; Bemis GW; Jacobs MD; Moody CS; Jajoo R; Mohal N; Green J
Bioorg Med Chem Lett; 2009 Jun; 19(11):3019-22. PubMed ID: 19414255
[TBL] [Abstract][Full Text] [Related]
17. The discovery and optimization of aminooxadiazoles as potent Pim kinase inhibitors.
Wurz RP; Pettus LH; Jackson C; Wu B; Wang HL; Herberich B; Cee V; Lanman BA; Reed AB; Chavez F; Nixey T; Laszlo J; Wang P; Nguyen Y; Sastri C; Guerrero N; Winston J; Lipford JR; Lee MR; Andrews KL; Mohr C; Xu Y; Zhou Y; Reid DL; Tasker AS
Bioorg Med Chem Lett; 2015 Feb; 25(4):847-55. PubMed ID: 25599837
[TBL] [Abstract][Full Text] [Related]
18. Investigations of linker structure on the potency of a series of bidentate protein tyrosine phosphatase inhibitors.
Xie J; Seto CT
Bioorg Med Chem; 2005 Apr; 13(8):2981-91. PubMed ID: 15781408
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of some 5-phenylisoxazole-3-carboxylic acid derivatives as potent xanthine oxidase inhibitors.
Wang S; Yan J; Wang J; Chen J; Zhang T; Zhao Y; Xue M
Eur J Med Chem; 2010 Jun; 45(6):2663-70. PubMed ID: 20189693
[TBL] [Abstract][Full Text] [Related]
20. Discovery of novel and potent heterocyclic carboxylic acid derivatives as protein tyrosine phosphatase 1B inhibitors.
Basu S; Prasad UV; Barawkar DA; De S; Palle VP; Menon S; Patel M; Thorat S; Singh UP; Das Sarma K; Waman Y; Niranjan S; Pathade V; Gaur A; Reddy S; Ansari S
Bioorg Med Chem Lett; 2012 Apr; 22(8):2843-9. PubMed ID: 22424978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
